Investors Communication

-----------------------------

Quarter & Nine Months Ended December 2022 : Q3 FY23

"This Presentation, except for the historical information, may contain statements, including the words or phrases such as 'expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should' and similar expressions or variations of these expressions or negatives of these terms indicating future performance or results, financial or otherwise of Tata Chemicals Limited, its direct and indirect subsidiaries and its associates. Actual results might differ substantially or materially from those expressed or implied. Important factors that could make a difference to the Company's operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas markets in which the Company operates, changes in Government policies and regulations, tax laws, and other statutes and incidental factors. You are urged to view all statements contained herein with caution. Tata Chemicals Limited does not undertake any obligation to update or revise forward look statements, whether as a result of new information, future events or otherwise"

2

3

Q3 FY23

9M FY23

Higher revenue on account of better realizations and

stable demand

Input costs still elevated but stable

  • 4,148 Cr (CY) vs ₹ 3,141Cr (PY)
  • 922 Cr (CY) vs. ₹ 546 Cr (PY)
  • 523 Cr (CY) vs. ₹ 246 Cr (PY)
  • 432 Cr (CY) vs ₹ 340 Cr (PY)
  • 12,382 Cr (CY) vs ₹ 9,141Cr (PY)
  • 2,857 Cr (CY) vs. ₹ 1,648 Cr (PY)
  • 1,773 Cr (CY) vs. ₹ 728 Cr (PY)
  • 1,758 Cr (CY) vs ₹ 930 Cr (PY)

EBITDA growth driven by higher realizations in all

geographies

Gross debt lower due to prepayment of debt US$ 144

Mn in overseas units during 9 months (Rs 1150 Cr)

Gross debt down from US $ 930 to US $ 780

Net debt primarily impacted by adverse exchange

rate movement with a forex revaluation impact

Gross Debt

₹ 7,024 Cr

548

₹ 6,476 Cr

(Mar 22)

(Dec 22)

Net Debt

₹ 4,232 Cr

125

₹ 4,357 Cr

(Mar 22)

(Dec 22)

of Rs 410 Cr

4

Revenue

4,239 4,148

3,141

Q3 Dec 21 Q2 Sep 22 Q3 Dec 22

Revenue up by ₹ 1,007 Crore (↑32%)

Consolidated | ₹ Crore

EBITDA

Profit Before Tax

Profit After Tax

920

922

723

685

546

406

534

340

432

Q3 Dec 21 Q2 Sep 22

Q3 Dec 22

Q3 Dec 21 Q2 Sep 22 Q3 Dec 22

Q3 Dec 21 Q2 Sep 22

Q3 Dec 22

EBITDA up by ₹ 376 Crore (↑69%)

PBT up by ₹ 128 Crore (↑32%)

PAT up by ₹ 92 Crore (↑27%)

Standalone | ₹ Crore

Revenue

EBITDA

Profit Before Tax

Profit After Tax

931

1,185

1,218

244

294

284

213

277

244

155

243

190

Q3 Dec

21 Q2 Sep 22

Q3 Dec 22

Q3 Dec 21

Q2 Sep 22

Q3 Dec 22

Q3 Dec

21

Q2 Sep 22

Q3 Dec 22

Q3 Dec

21

Q2 Sep 22

Q3 Dec

22

Revenue up by ₹ 287 Crore (↑31%)

EBITDA up by ₹ 40 Crore (↑16%)

PBT up by ₹ 31 Crore (↑15%)

PAT up by ₹ 35 Crore (↑23%)

Note: Change is vs PY quarter

5

PBT & PAT includes continuing operations, after share in JV & associates & before Non-Controlling Interest

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Tata Chemicals Limited published this content on 01 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2023 13:27:05 UTC.